Personalized Interventions Via Health Portraits in Mild Behavioral Impairment
Launched by FUJIAN PROVINCIAL HOSPITAL · May 15, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and improving the care of older adults who show signs of Mild Behavioral Impairment (MBI), a condition that may lead to dementia. Researchers are using a method called the Landmark model to predict how MBI might progress in individuals and to identify factors that could influence healthy aging. The trial aims to develop personalized, non-drug treatments that include activities like cognitive training, emotional support, and physical exercise tailored to each participant's needs.
To be eligible for this study, participants must be at least 60 years old, meet specific criteria for MBI, and be able to communicate effectively for assessments. Those with severe physical health issues or other neurological conditions may not qualify. Participants can expect to engage in various assessments and interventions aimed at managing their condition better. This trial is recruiting now, and it represents a promising effort to enhance the care for older adults at risk of dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meet the ISTAART diagnostic criteria for MBI;
- • Age ≥60 years old;
- • No obvious visual or hearing impairment;
- • Have the ability of language communication, can complete the scale assessment.
- Exclusion Criteria:
- • Patients with severe physical diseases and unable to complete cognitive function screening;
- • Patients with other neurological diseases and serious medical diseases that can cause brain dysfunction.
Trial Officials
Yuanjiao Yan, PhD
Study Director
Shengli clinical medical college of Fujian Medical university
About Fujian Provincial Hospital
Fujian Provincial Hospital is a leading medical institution in Fujian Province, China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge medical technology and multidisciplinary expertise to enhance patient care and contribute to the global medical community. With a focus on improving treatment outcomes across various specialties, Fujian Provincial Hospital adheres to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while fostering advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fuzhou, Fujian, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0